Synlait Milk to supply colostrum to ASX-listed Immuron 7 May 2012
- Hutson, Reeves seek SGM to vote on Janes ousting from Abano Business
- MARKET CLOSE: NZ shares rise on election speculation Business
- NZ dollar climbs to 2-week high vs. A$ on Aust CPI Business
- Food Safety Assurance Advisory Council established News
- Equity crowd funding carries risks, high failure rate Business
- McDonald’s NZ annual sales rise 5.8% Business
- NZ migration rises to 11-year high in March as fewer kiwis leave for Australia Migration
- Germany jumps to NZ’s fifth largest tourism market Travel
- Millennium & Copthorne mulls capital return Business
- MARKET CLOSE: NZ shares rise on Genesis sentiment Business
Synlait Milk, the Canterbury milk processor controlled by China’s Bright Dairy, has signed a deal to supply colostrum to ASX-listed biopharmaceutical company Immuron.
No value was put on the agreement. A spokesman for Synlait said his company planned a production run of the ‘hyperimmune colostrum’ in October. While the volumes would be small compared to Synlait’s total production, it was high-end in terms of value, said Synlait spokesman Michael Wan.
Immuron, which focusses on “oral immunotherapy treatments using dairy-derived antibody products for humans”, has a product for the prevention of diarrhoea, Travelan, on the market and several others in various stages of development, according to its statement.
“As Immuron embarks on an era of increased global distribution of Travelan and other products, it is imperative to have a partner able to accommodate the anticipated significant increase in supply capacity, chief executive Joe Baini said in the statement.
Shares of Immuron rose 5.9 percent to 1.8 Australian cents on the ASX today and have declined 66 percent this year.
Last month, the Melbourne-based company raised A$2 million via a A$1 million share placement and an underwritten A$1 million share purchase plan. Proceeds were to fund the rollout of Travelan and ongoing development of other products, it said at the time.
23 Apr 2014 News
An East Coast iwi says they are concerned the Crown has not made good on its promise to return their wharenui – the oldest... more
23 Apr 2014 Business News
Article - BusinessDesk Equity crowd funding, latest step in much-hyped social capital, carries risks, high failure rate By... more
22 Apr 2014 Entertainment
Film and Stage Producer/Director Craig Hutchison, is pleased to be representing New Zealand at the Sunset Film Festival in Los ... more
17 Apr 2014 Entertainment
The winner of the fourth annual Taite Music Prize 2013 is Lorde for her album ‘Pure Heroine’ released on Universal Music... more
7 Apr 2014 Property
April 7 (BusinessDesk) – New Zealand property values increased at the slowest annual pace in six months in March as lower... more
23 Apr 2014 Migration
April 23 (BusinessDesk) – New Zealand migration rose to an 11-year high in March, the second-highest gain on record, as fewer... more
28 Mar 2014 Migration
Citizens of Croatia aged between 18 and 30 will soon be eligible to apply for a New Zealand Working Holiday Visa, giving them the... more
23 Apr 2014 NZ Tourism
With 9,424 extra arrivals for the 12 months to the end of March, Germany has overtaken Japan to become New Zealand’s fifth... more
22 Apr 2014 Sport
The New Zealand Open team departs today to commence their World Cup campaign in Europe. Their first assault will be on the ICF Canoe... more
23 Apr 2014 Opinion
Shane Jones has left Parliament in the manner to which we have become accustomed, with self interest coming in first and second, and... more
23 Apr 2014 Appointments
Prime Minister John Key today announced the appointment of Cheryl Gwyn as Inspector-General of Intelligence and Security. The... more
17 Apr 2014 Appointments
April 17 (BusinessDesk) – Bank of New Zealand, the local unit of Australia’s third-biggest mortgage lender, named the... more
15 Apr 2014 Recruitment
The average annual wage is expected to increase by $7,500 to around $62,200 a year by 2018 if New Zealand achieves its ... more